Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
PALO ALTO INVESTORS LP | 05-15-2023 | 03-31-2023 | 30 | 1,207,102,207 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
BIOMARIN PHARMACEUTICAL INC | COM | 1 | $178,049,843 | 1,831,035 | 0.01 | 12.75 | -308,579 | -14.42 | 03-31-2023 |
REVANCE THERAPEUTICS INC | COM | 2 | $169,753,432 | 5,270,209 | 0.01 | 6.66 | 854,520 | 19.35 | 03-31-2023 |
UNITED THERAPEUTICS CORP | COM | 3 | $140,538,035 | 627,514 | 0.01 | 9.06 | -25,565 | -3.91 | 03-31-2023 |
AMICUS THERAPEUTICS INC | COM | 4 | $116,711,404 | 10,524,022 | 0.01 | 7.25 | 620,261 | 6.26 | 03-31-2023 |